What are the advantages and disadvantages of offshore companies?——Taking Evergrande Real Estate Group as an Example to Analyze Related Risks and Preventive Measures
Finance & Economics · 2024
DOI: 10.61173/06qp8d62 ↗Kurz gefasst
Fachartikel in der Zeitschrift Finance & Economics, 2024. Verfasst von Wenjing Qian. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This article takes the phenomenon of “offshore companies” as the main research direction, supplemented by the analysis of potential risks of Evergrande Real Estate Group as a practical case, and attempts to provide certain suggestions for the compliance construction of similar enterprises in the future.This article adopts a combination of literature review and case analysis methods for research. Firstly, by consulting relevant materials, explain the concepts, characteristics, and advantages of offshore companies compared to general limited companies. Secondly, using case analysis method, elaborate on the potential risks of offshore companies. Finally, by referring to and drawing on the existing systems of international organizations and the United Kingdom, it is possible to establish and improve corresponding legal regulations in China in the future.
Zitieren
APA
Qian, W. (2024). What are the advantages and disadvantages of offshore companies?——Taking Evergrande Real Estate Group as an Example to Analyze Related Risks and Preventive Measures. Finance & Economics. https://doi.org/10.61173/06qp8d62
Vancouver
Qian W. What are the advantages and disadvantages of offshore companies?——Taking Evergrande Real Estate Group as an Example to Analyze Related Risks and Preventive Measures. Finance & Economics. 2024. doi:10.61173/06qp8d62
BibTeX
@article{Qian2024,
author = {Qian, Wenjing},
title = {What are the advantages and disadvantages of offshore companies?——Taking Evergrande Real Estate Group as an Example to Analyze Related Risks and Preventive Measures},
journal = {Finance & Economics},
year = {2024},
doi = {10.61173/06qp8d62}
}
EUVIMED